Outcomes of multiple Dexamethasone injections and conversion to Ranibizumab in patients with retinal vein occlusion macular oedema

Trial Profile

Outcomes of multiple Dexamethasone injections and conversion to Ranibizumab in patients with retinal vein occlusion macular oedema

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Feb 2018

At a glance

  • Drugs Ranibizumab (Primary) ; Dexamethasone
  • Indications Retinal oedema
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Feb 2018 New trial record
    • 01 Jan 2018 Results published in the Ophthalmologica
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top